1. Editorial Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives

   • Thomas Müller

   Editorial Open access 27 April 2018 Pages: 1 - 3

2. Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate

   • Mortimer Mamelak

   Commentary Open access 24 January 2018 Pages: 5 - 11

3. Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives

   • Elisabet Londos

   Commentary Open access 19 December 2017 Pages: 13 - 22

4. Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Patient Education

   • Daniel Kantor
   • Jeremy R. Bright
   • Jeri Burtchell

   Commentary Open access 14 December 2017 Pages: 23 - 36

5. Perspectives from the Patient and the Healthcare Professional in Multiple Sclerosis: Social Media and Participatory Medicine

   • Daniel Kantor
   • Jeremy R. Bright
   • Jeri Burtchell

   Commentary Open access 08 December 2017 Pages: 37 - 49

6. 5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress

   • Megan Andrews
   • Babak Tousi
   • Marwan N. Sabbagh

   Review Open access 02 May 2018 Pages: 51 - 58

7. Vitamin D and Multiple Sclerosis: A Comprehensive Review

   • Martina B. Sintzel
   • Mark Rametta
   • Anthony T. Reder

   Review Open access 14 December 2017 Pages: 59 - 85

   

8. Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)

   • Rajiv Mundayat
   • Michelle Stewart
   • Marla B. Sultan

   Original Research Open access 09 April 2018 Pages: 87 - 101

   

9. ATX-MS-1467 Induces Long-Term Tolerance to Myelin Basic Protein in (DR2 × Ob1)F1 Mice by Induction of IL-10-Secreting iTregs

   • Adriano Luís Soares De Souza
   • Stefan Rudin
   • Tammy Dellovade

   Original Research Open access 14 March 2018 Pages: 103 - 128

   

10. A Phase IC Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Cognitive Outcomes of BI 409306 in Patients with Mild-to-Moderate Schizophrenia

    • David Brown
    • Kristen Daniels
    • Michael Sand

    Original Research Open access 24 November 2017 Pages: 129 - 139

    

11. Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches

    • Daniel Serrano
    • Christopher B. Atzinger
    • Marc F. Botteman

    Brief Report Open access 02 April 2018 Pages: 141 - 154

    

12. Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series

    • Jacobo Lester
    • Gerardo Esteban Alvarez-Resendiz
    • Gerardo Zambito

    Case Series Open access 30 January 2018 Pages: 155 - 159

13. Letter to the Editor Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives

    • Maksymilian Aleksander Brzezicki
    • Matthew David Kobetić

    Letter Open access 27 April 2018 Pages: 161 - 163

    

14. Author’s Response to the Letter to the Editor Regarding: Practical Treatment of Lewy Body Disease in the Clinic: Patient and Physician Perspectives

    • Elisabet Londos

    Letter Open access 27 April 2018 Pages: 165 - 167

15. Correction to: Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study

    • Michael Dennis
    • Laura Shine
    • Sinead Brophy

    Correction Open access 09 March 2018 Pages: 169 - 169